Clinical Trial

An Open-label Long-term Safety Study of Buntanetap in Participants With AD

Name: An Open-label Long-term Safety Study of Buntanetap in Participants With AD — clinical trial record (NCT07757204)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.

Trial Details

NCT Number	NCT07757204
Lead Sponsor	Annovis Bio Inc.
Conditions	Alzheimer's Dementia (AD)
Enrollment	400 participants
Start Date	2026-09-21
Primary Completion	2030-02-21 (estimated)
Study Completion	2030-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-11